With Zoetis poised to benefit from the expected growth in the global swine healthcare and U.S. companion animal diagnostics markets, along with their ...
Read More
With Zoetis poised to benefit from the expected growth in the global swine healthcare and U.S. companion animal diagnostics markets, along with their recent earnings beats and raised guidance, I believe their stock is a strong buy for long-term gains.